233 related articles for article (PubMed ID: 21646624)
21. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.
Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
Eur J Neurol; 2011 Feb; 18(2):337-342. PubMed ID: 20629714
[TBL] [Abstract][Full Text] [Related]
22. EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study.
Sundström P; Nyström L; Jidell E; Hallmans G
Mult Scler; 2008 Sep; 14(8):1120-2. PubMed ID: 18573815
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and association of human papillomavirus 16, Epstein-Barr virus, herpes simplex virus-1 and cytomegalovirus infection with human esophageal carcinoma: a case-control study.
Zhang DH; Zhang QY; Hong CQ; Chen JY; Shen ZY; Zhu Y
Oncol Rep; 2011 Jun; 25(6):1731-8. PubMed ID: 21455581
[TBL] [Abstract][Full Text] [Related]
24. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
[TBL] [Abstract][Full Text] [Related]
25. The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.
Tuwir I; Dunne C; Crowley J; Saddik T; Murphy R; Cassidy L
Br J Ophthalmol; 2007 Oct; 91(10):1288-92. PubMed ID: 17895416
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
[TBL] [Abstract][Full Text] [Related]
27. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.
Zhang Q; Lin CY; Dong Q; Wang J; Wang W
Autoimmun Rev; 2011 Jun; 10(8):474-81. PubMed ID: 21440682
[TBL] [Abstract][Full Text] [Related]
28. HLA class II polymorphism in Latin American patients with multiple sclerosis.
Rojas OL; Rojas-Villarraga A; Cruz-Tapias P; Sánchez JL; Suárez-Escudero JC; Patarroyo MA; Anaya JM
Autoimmun Rev; 2010 Apr; 9(6):407-13. PubMed ID: 19896562
[TBL] [Abstract][Full Text] [Related]
29. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
[TBL] [Abstract][Full Text] [Related]
30. Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status.
Isobe N; Matsushita T; Yamasaki R; Ramagopalan SV; Kawano Y; Nishimura Y; Ebers GC; Kira J
Mult Scler; 2010 Feb; 16(2):147-55. PubMed ID: 20028711
[TBL] [Abstract][Full Text] [Related]
31. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.
Chao MJ; Barnardo MC; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Montpetit A; Sadovnick AD; Knight JC; Ebers GC
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13069-74. PubMed ID: 18765817
[TBL] [Abstract][Full Text] [Related]
32. HLA-DRB1*15:01 is a co-receptor for Epstein-Barr virus, linking genetic and environmental risk factors for multiple sclerosis.
Menegatti J; Schub D; Schäfer M; Grässer FA; Ruprecht K
Eur J Immunol; 2021 Sep; 51(9):2348-2350. PubMed ID: 34019695
[TBL] [Abstract][Full Text] [Related]
33. Seropositivity of neurotropic infectious agents in first-episode schizophrenia patients and the relationship with positive and negative symptoms.
Bolu A; Oznur T; Tok D; Balikci A; Sener K; Celik C; Gulsun M
Psychiatr Danub; 2016 Jun; 28(2):132-8. PubMed ID: 27287787
[TBL] [Abstract][Full Text] [Related]
34. A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls.
Maple PAC; Tanasescu R; Gran B; Constantinescu CS
J Infect; 2020 Mar; 80(3):320-325. PubMed ID: 31678173
[TBL] [Abstract][Full Text] [Related]
35. Role of early viral infections in development of multiple sclerosis.
Djelilovic-Vranic J; Alajbegovic A
Med Arch; 2012; 66(3 Suppl 1):37-40. PubMed ID: 22937690
[TBL] [Abstract][Full Text] [Related]
36. Common Childhood Viruses and Pubertal Timing: The LEGACY Girls Study.
McDonald JA; Cherubin S; Goldberg M; Wei Y; Chung WK; Schwartz LA; Knight JA; Schooling CM; Santella RM; Bradbury AR; Buys SS; Andrulis IL; John EM; Daly MB; Terry MB
Am J Epidemiol; 2021 May; 190(5):766-778. PubMed ID: 33128063
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.
Mowry EM; James JA; Krupp LB; Waubant E
Mult Scler; 2011 Jun; 17(6):666-71. PubMed ID: 21212086
[TBL] [Abstract][Full Text] [Related]
39. Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years.
Svahn A; Berggren J; Parke A; Storsaeter J; Thorstensson R; Linde A
J Clin Virol; 2006 Oct; 37(2):118-23. PubMed ID: 16971177
[TBL] [Abstract][Full Text] [Related]
40. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
